TIM3, as a member of TIM family, has been identified as an important immune checkpoint inhibitor that plays an important role in modulating dysfunctional or exhausted CD8+ T cells in chronic diseases such as cancer (Sakuishi et al., 2013). The gene discussed is HAVCR2; the disease is cancer.